Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review
Yen-Wen Chen,1 Pao-Yen Lin,2,3 Kun-Yu Tu,4 Yu-Shian Cheng,4 Ching-Kuan Wu,4 Ping-Tao Tseng4 1Department of Neurology, E-Da Hospital, 2Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, 3Center for Translational Research in Biomedical Sci...
Guardado en:
Autores principales: | Chen YW, Lin PY, Tu KY, Cheng YS, Wu CK, Tseng PT |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f967302f6584080ae9c004c725bb8ce |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Age-associated decrease in global DNA methylation in patients with major depression
por: Tseng PT, et al.
Publicado: (2014) -
Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: a meta-analysis of randomized controlled trials
por: Cheng YS, et al.
Publicado: (2017) -
Association between peripheral manganese levels and attention-deficit/hyperactivity disorder: a preliminary meta-analysis
por: Shih JH, et al.
Publicado: (2018) -
The severe complication of Stevens–Johnson syndrome induced by long-term clozapine treatment in a male schizophrenia patient: a case report
por: Wu MK, et al.
Publicado: (2015) -
Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment
por: Lee BH, et al.
Publicado: (2014)